Quantum Genomics
ALQGC | PA
Overview
Corporate Details
- ISIN(s):
- FR0010783837 (+4 more)
- LEI:
- 969500TFCD8K9RPM9K97
- Country:
- France
- Address:
- 6 RUE CAMBACERES, 75008 PARIS
- Website:
- https://quantum-genomics.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Quantum Genomics is a biopharmaceutical company that has historically specialized in the research and development of a new class of drugs for cardiovascular diseases, particularly resistant hypertension and heart failure. The company's core innovation was based on Brain Aminopeptidase A Inhibition (BAPAI), a novel mechanism targeting the brain to regulate blood pressure, with firibastat as its lead drug candidate. Following a strategic reorientation in 2024, Quantum Genomics acquired ExactCure, a company developing a digital twin solution. This technology aims to simulate drug effects in individual patients to optimize dosage, personalize treatments, and prevent adverse drug interactions, shifting the company's focus towards personalized medicine and digital health solutions.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Quantum Genomics.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-13 18:00 |
Post-Annual General Meeting Information
Report de l'Assemblée Générale Mixte du 30/06/2025
|
French | 116.4 KB | |
| 2025-04-30 20:00 |
Earnings Release
Quantum Genomics publishes its 2024 annual financial statements and announces a…
|
English | 206.5 KB | |
| 2025-04-30 20:00 |
Delisting Announcement
Quantum Genomics publie ses comptes annuels 2024 et annonce un changement de li…
|
French | 254.0 KB | |
| 2025-04-08 08:00 |
Delisting Announcement
Quantum Genomics fait un point sur sa situation
|
French | 688.8 KB | |
| 2025-04-08 08:00 |
Delisting Announcement
Quantum Genomics provides an update on its situation
|
English | 626.0 KB | |
| 2024-10-29 18:00 |
Earnings Release
Quantum Genomics publie ses résultats du 1er semestre 2024 et annonce la nomina…
|
French | 241.2 KB | |
| 2024-09-27 08:00 |
Legal Proceedings Report
Quantum Genomics sécurise un financement avec le fonds Akkadian Partners Fund e…
|
French | 74.5 KB | |
| 2024-09-04 18:00 |
Legal Proceedings Report
Quantum Genomics reviewed its financial situation and announced that it has fil…
|
English | 175.5 KB | |
| 2024-09-04 18:00 |
Legal Proceedings Report
Quantum Genomics fait un point sur sa situation financière et annonce qu'elle a…
|
French | 150.0 KB | |
| 2024-07-03 13:00 |
Capital/Financing Update
BILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE…
|
French | 275.3 KB | |
| 2024-03-13 18:00 |
Business and Financial Review
Quantum Genomics publie ses résultats de l'exercice 2023. Le rapprochement avec…
|
French | 193.8 KB | |
| 2024-03-13 18:00 |
Earnings Release
Quantum Genomics publishes its results for the 2023 financial year. The merger …
|
English | 166.3 KB | |
| 2024-01-10 16:35 |
Capital/Financing Update
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
| 2024-01-10 16:30 |
Capital/Financing Update
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | |
| 2023-12-14 18:05 |
Regulatory News Service
Quantum Genomics enters into exclusive negotiations with ExactCure
|
English | 286.1 KB |
Automate Your Workflow. Get a real-time feed of all Quantum Genomics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Quantum Genomics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
